Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2026-03-31 Audit Report / Informat…
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Sprawozdanie niezależnego biegłego rewidenta z badania (grupa kapitałowa) pdf
Audit Report / Information Classification · 93% confidence The document is a standalone auditor’s report (“Sprawozdanie niezależnego biegłego rewidenta”) on the consolidated annual financial statements of Selvita S.A., containing the audit opinion, basis for opinion, key audit matters, and auditor’s responsibilities. It does not constitute the full annual report but is clearly an independent audit report, matching the Audit Report / Information definition. FY 2025
2026-03-31 Polish
Ocena Rady Nadzorczej Selvita S.A. dotycząca sprawozdań Zarządu z działalności oraz sprawozdań finansowych Selvita S.A. i Grupy Kapitałowej Selvita
Regulatory Filings Classification · 85% confidence The document is a Supervisory Board statement assessing the Management Board’s and audit reports for the 2025 financial year. It is not the full annual report itself, nor an audit report (it references the auditor’s reports but is not one), nor an earnings release, dividend notice, or management discussion. It does not announce publication timing of a report (so not RPA) and does not cover board changes, financing, or M&A. Therefore it falls under the misc. regulatory filings category as a current regulatory disclosure by the issuer.
2026-03-31 Polish
Oświadczenie Rady Nadzorczej Selvita S.A. dotyczące funkcjonowania Komitetu Audytu oraz firmy audytorskiej w Selvita S.A. oraz Grupie Kapitałowej Selvita
Regulatory Filings Classification · 67% confidence The document is a standalone statement by the Supervisory Board regarding compliance with audit committee rules and auditor rotation in connection with the publication of the annual report. It is not the annual report itself, nor a financial supplement, nor a management change notice. It does not announce dividend, financing, or share transactions. It is a mandatory periodic disclosure under Polish regulations and does not fit a more specific filing type, so it falls under the general Regulatory Filings (RNS) category.
2026-03-31 Polish
Consolidated Financial Statements pdf
Annual Report Classification · 100% confidence The document is titled 'CONSOLIDATED FINANCIAL STATEMENTS Prepared for the period from 01/01/2025 to 31/12/2025' and contains detailed financial statements including the consolidated statement of comprehensive income, statement of financial position, statement of changes in equity, statement of cash flows, and extensive notes to the consolidated financial statements. The period covered is a full fiscal year (2025). The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or certification. The content and structure align with a comprehensive annual report covering full financial performance for the year, consistent with the definition of an Annual Report (10-K). FY 2025
2026-03-31 Polish
Skonsolidowane sprawozdanie finansowe roczne zip.xades
Regulatory Filings
2026-03-31 Polish
Skonsolidowane sprawozdanie finansowe roczne zip
Annual Report (ESEF) Classification · 100% confidence FY 2025
2026-03-31 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.